not really 200 million +market cap-whole different company. CEO Caruso or what ever is a drunk Bum that knows nothing on how to run a BIO tech company. the only thing this company does is reverse the stock when the stock goes below a dollar to stay on NASD. CEO screwed over every investor over the last couple of years.